C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies

Patents for C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies (149,320)
12/2011
12/13/2011	CA2441048C Novel compound for treatment of allergy and asthma
12/13/2011	CA2402238C Polypeptides having neutrophil stimulating activity
12/13/2011	CA2358520C Soluble receptor br43x2 and methods of using
12/13/2011	CA2350165C Novel serine protease bssp6
12/08/2011	WO2011153300A2 Monoclonal antibodies detection methods for enzymes that confer resistance to 2,4-dichlorophenoxyacetic acid in plants
12/08/2011	WO2011152722A2 Cloning and exploitation of a functional r-gene from solanum x edinense
12/08/2011	WO2011152525A1 Antibody and use thereof
12/08/2011	WO2011152503A1 Treatment drug for autoimmune diseases and allergic diseases
12/08/2011	WO2011152071A1 Novel hyaluronic acid decomposition-promoting factor and inhibitor thereof
12/08/2011	WO2011151432A1 Humanised antigen binding proteins to myostatin6
12/08/2011	WO2011151412A1 Novel anti-cmet antibody
12/08/2011	WO2011151076A2 MONOCLONAL ANTIBODIES TARGETING Αβ OLIGOMERS
12/08/2011	WO2011150690A1 Monoclonal antibody against granulocyte of chlamys farreri and preparation method thereof
12/08/2011	WO2011150454A1 ANTIBODIES DIRECTED TO THE UNPROCESSED RECEPTOR TYROSINE KINASE c-MET
12/08/2011	WO2011150453A1 Diagnostic, prognostic and therapeutic use of a long non-coding rna
12/08/2011	WO2011130377A3 Amyloid-beta binding proteins
12/08/2011	WO2011102999A3 Spink1 targeted therapy
12/08/2011	WO2011062634A3 Monoclonal antibodies and diagnostic uses thereof
12/08/2011	WO2011041350A3 Xenotropic mulv-related virus (xmrv) compositions and methods of use
12/08/2011	WO2010087743A8 The use of basigin-1 in stem cell and cancer applications
12/08/2011	WO2010072741A9 TARGETED BINDING AGENTS DIRECTED TO α5β1 AND USES THEREFOR
12/08/2011	US20110302674 Methods and Compositions for the Improvement of Plant Tolerance to Environmental Stresses
12/08/2011	US20110302670 Polynucleotides and methods for the improvement of plants
12/08/2011	US20110301339 Novel inhibitors of vascular endothelial growth factor activity, their uses and processes for their production
12/08/2011	US20110301338 Novel inhibitors of vascular endothelial growth factor activity, their uses and processes for their production
12/08/2011	US20110301337 Novel inhibitors of vascular endothelial growth factor activity, their uses and processes for their production
12/08/2011	US20110301336 Antibody produced using ostrich and method for production thereof
12/08/2011	US20110301335 Anti-tnfr1 polypeptides, antibody variable domains & antagonists
12/08/2011	US20110301334 Cysteine engineered antibodies and conjugates
12/08/2011	US20110301333 Removal of protein aggregates from biopharmaceutical preparations using calcium phosphate salts
12/08/2011	US20110301332 Anti-pamp therapeutic antibodies
12/08/2011	US20110301331 Stabilized polypeptide compositions
12/08/2011	US20110300642 Methods for differentiating and monitoring parathyroid and bone status related diseases
12/08/2011	US20110300641 Protein isoforms for diagnosis
12/08/2011	US20110300578 Novel inhibitors of vascular endothelial growth factor activity, their uses and processes for their production
12/08/2011	US20110300577 Novel inhibitors of vascular endothelial growth factor activity, their uses and processes for their production
12/08/2011	US20110300559 Compositions and methods for diagnosing and treating cancer and neurodegenerative diseases related to beclin-1
12/08/2011	US20110300557 METHODS FOR PREDICTING PREGNANCY OUTCOME IN A SUBJECT BY hCG ASSAY
12/08/2011	US20110300556 Monoclonal antibodies detection methods for enzymes that confer resistance to 2,4-dichlorophenoxyacetic acid in plants
12/08/2011	US20110300185 Immunogenic escherichia coli heat stable enterotoxin
12/08/2011	US20110300176 Microorganisms for therapy
12/08/2011	US20110300160 Sulfation of wnt pathway proteins
12/08/2011	US20110300159 Sulfonated Sclerostin, antibodies, epitopes and methods for identification and use therefor
12/08/2011	US20110300158 Anti-serum albumin binding variants
12/08/2011	US20110300157 Metalloproteinase 9 and metalloproteinase 2 binding proteins
12/08/2011	US20110300156 Human antibodies against tissue factor
12/08/2011	US20110300148 Il-4-derived peptides for modulation of the chronic inflammatory response and treatment of autoimmune diseases
12/08/2011	US20110300147 Inhibiting tumor cell invasion, metastasis and angiogenesis
12/08/2011	US20110300145 Interferon Alpha Antibodies And Their Uses
12/08/2011	US20110300144 Methods and compositions for diagnosis and treatment of cancer
12/08/2011	US20110300140 Antigen binding polypeptides
12/08/2011	US20110300139 Generation, expression and characterization of the humanized k33n monoclonal antibody
12/08/2011	US20110300138 Human anti tshr antibodies
12/08/2011	US20110300136 Therapy of autoimmune disease in a patient with an inadequate response to a tnf-alpha inhibitor
12/08/2011	US20110300133 Chimeric and humanized antibodies to alpha5beta1 integrin that modulate angiogenesis
12/08/2011	US20110300131 Detection and treatment of pancreatic, ovarian and other cancers
12/08/2011	US20110300128 Use of foxp2 as a marker for abnormal lymphocytes and as a target for therapy of disorders associated with abnormal lymphocytes
12/08/2011	US20110300113 Death Receptor CD95 Controls Neurogenesis of Adult Neural Stem Cells in Vivo and in Vitro
12/08/2011	US20110300098 Methods of treating cancer using il-21 and monoclonal antibody therapy
12/08/2011	US20110300077 Human Anti-Alpha-Synuclein Antibodies
12/08/2011	US20110300068 Agent for prophylaxis or treatment of cancer
12/08/2011	DE102004010928B4 Protein zur Bindung prokaryonter DNA sowie Verfahren zur Trennung und Anreicherung prokaryonter DNA Protein binding to prokaryotic DNA as well as methods for the separation and enrichment of prokaryotic DNA
12/08/2011	CA2805270A1 Treatment of inflammatory disorders
12/08/2011	CA2801917A1 Uses and compositions for treatment of hidradenitis suppurativa (hs)
12/08/2011	CA2801802A1 Humanised antigen binding proteins to myostatin6
12/08/2011	CA2801509A1 Treatment drug for autoimmune diseases and allergic diseases
12/08/2011	CA2801264A1 Novel anti-cmet antibody
12/08/2011	CA2801184A1 Peripheral blood sparc binding antibodies and uses thereof
12/08/2011	CA2800531A1 Humanized monoclonal antibodies and methods of use
12/08/2011	CA2800281A1 Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of lysyl-trna synthetases
12/08/2011	CA2799439A1 Monoclonal antibodies detection methods for enzymes that confer resistance to 2,4-dichlorophenoxyacetic acid in plants
12/08/2011	CA2797875A1 Cloning and exploitation of a functional r-gene from solanum x edinense
12/07/2011	EP2392923A1 Method of prodcucing proteins comprising unnatural amino acid
12/07/2011	EP2392667A2 Assay for phosphodiesterases
12/07/2011	EP2392659A2 Single domain TDF-related compounds and analogs thereof
12/07/2011	EP2392598A1 Monoclonal antibody SC104 and derivative thereof specifically binding to a sialyltetraosyl carbohydrate as a potential anti-tumor therapeutic agent
12/07/2011	EP2392597A2 Antagonists to IL-17A, IL-17F, and IL-23P19 and methods of use
12/07/2011	EP2392596A2 Intrabodies with defined framework that is stable in a reducing environment and applications thereof
12/07/2011	EP2392593A2 Differential in tumour gene products and use of same
12/07/2011	EP2392353A1 Anti A beta antibody formulation
12/07/2011	EP2392351A1 Hiv replication inhibitor, and use thereof
12/07/2011	EP2392350A1 Methods for treating conditions associated with MASP-2 dependent complement activation
12/07/2011	EP2391654A1 Urine and serum biomarkers associated with diabetic nephropathy
12/07/2011	EP2391653A1 Biomarkers associated with nephropathy
12/07/2011	EP2391652A2 Il-1 binding proteins
12/07/2011	EP2391651A1 Eotaxin-2 (ccl24) inhibitors in inflammatory, autoimmune, and cardiovascular disorders
12/07/2011	EP2391650A1 Methods for the treatment of gout
12/07/2011	EP2391649A1 Tslp promotes immune evasion and persistence of viruses
12/07/2011	EP2391641A2 Novel peptides and methods for producing them
12/07/2011	EP2391640A1 A clostridium chauvoei polypeptide, dna encoding the polypeptide and a vaccine comprising the polypeptide
12/07/2011	EP2391384A1 Human anti-il-6 antibodies with extended in vivo half-life and their use in treatment of oncology, autoimmune diseases and inflammatory diseases
12/07/2011	EP2064325B1 Enhanced expression of human or humanized immunoglobulin in non-human transgenic animals
12/07/2011	EP1993601B1 Non-coiled protective regions of pneumococcal surface proteins pspa and pspc
12/07/2011	EP1945665B1 Antibody-based therapeutics with enhanced adcc activity
12/07/2011	EP1706427B1 Human binding molecule against cd1a
12/07/2011	EP1566635B1 Microwell array chip for detecting antigen-specific lymphocyte, method of detecting antigen-specific lymphocyte and method of cloning antigen-specific lymphocyte antigen receptor gene
12/07/2011	EP1534335B1 Fcgammariib-specific antibodies and methods of use thereof
12/07/2011	EP1457558B1 Weed controller metabolism proteins, genes thereof and use of the same
12/07/2011	EP1450605B1 Composition to alter bone properties in a subject
12/07/2011	EP1294770B1 Human igm antibodies with the capability of inducing remyelination, and diagnostic and therapeutic uses thereof particularly in the central nervous system

1 ... 228 229 230 231 232 233 234 235 236 237 238 239 240 241 242 243 244 245 246 247 248 ... 1494